YU35602A - Oblici 5-((6-((2-fluorofenil)metoksi)-2-naftalenil)metil)- 2,4-tiazolidindiona u čvrstom stanju - Google Patents

Oblici 5-((6-((2-fluorofenil)metoksi)-2-naftalenil)metil)- 2,4-tiazolidindiona u čvrstom stanju

Info

Publication number
YU35602A
YU35602A YU35602A YUP35602A YU35602A YU 35602 A YU35602 A YU 35602A YU 35602 A YU35602 A YU 35602A YU P35602 A YUP35602 A YU P35602A YU 35602 A YU35602 A YU 35602A
Authority
YU
Yugoslavia
Prior art keywords
naphthalenyl
fluorophenyl
methoxy
methyl
thiazolidindione
Prior art date
Application number
YU35602A
Other languages
English (en)
Inventor
Mark C. Andres
Stephen R. Bryn
Ann W. Newman
Catherine Russell
Original Assignee
Ortho-Mcneil Pharmaceutical Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical Inc. filed Critical Ortho-Mcneil Pharmaceutical Inc.
Publication of YU35602A publication Critical patent/YU35602A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Prikazani pronalazak obezbedjuje kristalni oblik, koji je nazvan kristalni oblik tipa E i amorfni oblik 5-[[6-[2-fluorofenil)metoksi[-2-naftalenil]metil]-2,4-tiazolidindiona (MCC-555) koji su različiti od poznatih kristalnih formi. Prikazani pronalazak takodje obezbedjuje postupak njegovog dobijanja i farmaceutske kompozicije koje sadrže kristalni oblik tipa E ili amorfne oblike MCC-555.[The present invention provides a crystal form, termed E type crystal form, and an amorphous form of 5-[[6-[(2-fluorophenyl)methoxy]- 2-naphthalenyl]methyl]-2,4-Thiazolidinedione (MCC-555) that are distinguishable from known crystal forms. The present invention also provides a method for preparation thereof and pharmaceutical compositions comprising the E type crystal form, or amorphous forms of MCC-555.
YU35602A 1999-11-19 2000-11-17 Oblici 5-((6-((2-fluorofenil)metoksi)-2-naftalenil)metil)- 2,4-tiazolidindiona u čvrstom stanju YU35602A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16651599P 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
YU35602A true YU35602A (sh) 2006-05-25

Family

ID=22603643

Family Applications (1)

Application Number Title Priority Date Filing Date
YU35602A YU35602A (sh) 1999-11-19 2000-11-17 Oblici 5-((6-((2-fluorofenil)metoksi)-2-naftalenil)metil)- 2,4-tiazolidindiona u čvrstom stanju

Country Status (16)

Country Link
EP (1) EP1235817A1 (sh)
JP (1) JP2003514807A (sh)
CN (1) CN1423639A (sh)
AR (1) AR029409A1 (sh)
AU (1) AU1776701A (sh)
BG (1) BG106692A (sh)
BR (1) BR0015702A (sh)
CA (1) CA2391429A1 (sh)
HU (1) HUP0203280A3 (sh)
IL (1) IL149593A0 (sh)
MX (1) MXPA02005008A (sh)
NO (1) NO20022329L (sh)
RU (1) RU2002113123A (sh)
WO (1) WO2001036401A1 (sh)
YU (1) YU35602A (sh)
ZA (1) ZA200204873B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055774A (zh) * 2013-03-22 2014-09-24 天津药物研究院 一种稳定的非晶态盐酸吡格列酮复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
JP4023697B2 (ja) * 1996-11-14 2007-12-19 三菱化学株式会社 ナフタレン誘導体の製造方法
PL348502A1 (en) * 1998-11-20 2002-05-20 Mitsubishi Chem Corp Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Also Published As

Publication number Publication date
MXPA02005008A (es) 2003-10-14
CA2391429A1 (en) 2001-05-25
BR0015702A (pt) 2002-07-16
HUP0203280A3 (en) 2003-07-28
IL149593A0 (en) 2002-11-10
EP1235817A1 (en) 2002-09-04
HUP0203280A2 (hu) 2003-01-28
CN1423639A (zh) 2003-06-11
AR029409A1 (es) 2003-06-25
WO2001036401A1 (en) 2001-05-25
NO20022329L (no) 2002-07-09
RU2002113123A (ru) 2004-01-20
ZA200204873B (en) 2003-11-26
JP2003514807A (ja) 2003-04-22
NO20022329D0 (no) 2002-05-15
AU1776701A (en) 2001-05-30
BG106692A (bg) 2003-03-31

Similar Documents

Publication Publication Date Title
EE05531B1 (et) Tert-butl-(E)-(6-{2-[4-(4-fluorofenl)-6-isopropl-2-[metl(metlsulfonl)amino]primidiin-5-l]vinl}(4R, 6S)-2,2-dimetl[1,3]dioksaan-4-l)atsetaadi valmistamismeetod
EP1276738B8 (en) 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
WO1999002497A3 (en) Pyridine derivatives
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
WO2005021497A3 (en) Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
ZA974984B (en) New substituted thiazolidine-2,4-dione derivatives, processes for the obtaining thereof, and pharmaceutical compositions containing them.
IL128505A (en) Process for the preparation of (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy) phenyl]-3-methoxypropenoate
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
YU35602A (sh) Oblici 5-((6-((2-fluorofenil)metoksi)-2-naftalenil)metil)- 2,4-tiazolidindiona u čvrstom stanju
DZ2430A1 (fr) Procédé pour la préparation de dérivés de thiazolidinedione substitués.
DK1233961T3 (da) Fremgangsmåde til fremstilling af 5-(1-piperazinyl)-benzofuran-2-carboxamid ved overgangsmetal-katalyseret aminering
AU2002343036A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EG22745A (en) 2-(3,5-Disbustituted-4-pyridyl)-4-(thienyl) thiazolyl or arylphenyl)1,30xazoline compounds
AU6103399A (en) Substituted pyrrolidinone, thiazolidinone or oxazolidinone as herbicides
AU558668B2 (en) Formulation of antiinflammatory drugs
DK1383763T3 (da) Fremgangsmåde til fremstilling af 2-(-5-(4-fluorphenyl)-3-pyridylmethylaminomethyl)-chroman
HUP0103517A3 (en) Improved process for the preparation of thiazolidine-2,4-dione derivatives
HUP0104139A3 (en) Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
MXPA03007624A (es) Procedimiento para la preparacion de (e)-5-(2-bromovinil)-2-desoxiuridina.
AU2003269483A1 (en) Phosphoric acid salt of 5-((4-(2-(methyl-2-pyridinylamino) ethoxy) phenyl) methyl)- 2,4-thiazolidinedione
AU2002238645A1 (en) Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
FR2764601B1 (fr) Procede de preparation de composes de type 4-(alkyl)-3- alcoxy-anilines
AU5514199A (en) Process for the preparation of 2-(aryloxymethyl)-2,5,7,8-tetramethylchroman-6-ols